These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2939246

  • 21. Comparison in rats of the anti-inflammatory and gastric irritant effects of etodolac with several clinically effective anti-inflammatory drugs.
    Martel RR, Klicius J.
    Agents Actions; 1982 Jul; 12(3):295-7. PubMed ID: 6215841
    [Abstract] [Full Text] [Related]

  • 22. A Comprehensive Review on Pyranoindole-containing Agents.
    Catalano A, Iacopetta D, Ceramella J, Saturnino C, Sinicropi MS.
    Curr Med Chem; 2022 Jul; 29(21):3667-3683. PubMed ID: 34872472
    [Abstract] [Full Text] [Related]

  • 23. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.
    Charifson PS, Bowen JP, Wyrick SD, Hoffman AJ, Cory M, McPhail AT, Mailman RB.
    J Med Chem; 1989 Sep; 32(9):2050-8. PubMed ID: 2527994
    [Abstract] [Full Text] [Related]

  • 24. The effect of the non-steroidal anti-inflammatory drug Etodolac on macrophage migration in vitro and in vivo.
    Gervais F, Martel RR, Skamene E.
    J Immunopharmacol; 1984 Sep; 6(3):205-14. PubMed ID: 6238099
    [Abstract] [Full Text] [Related]

  • 25. A surprising switch in absolute configuration of anti-inflammatory macrolactones.
    Tauber J, Rohr M, Walter T, Schollmeyer D, Rahn-Hotze K, Erkel G, Opatz T.
    Org Biomol Chem; 2016 Apr 12; 14(15):3695-8. PubMed ID: 27035902
    [Abstract] [Full Text] [Related]

  • 26. (R)-(-)- and (S)-(+)-Synadenol: synthesis, absolute configuration, and enantioselectivity of antiviral effect.
    Qiu YL, Hempel A, Camerman N, Camerman A, Geiser F, Ptak RG, Breitenbach JM, Kira T, Li L, Gullen E, Cheng YC, Drach JC, Zemlicka J.
    J Med Chem; 1998 Dec 17; 41(26):5257-64. PubMed ID: 9857093
    [Abstract] [Full Text] [Related]

  • 27. Etodolac clinical pharmacokinetics.
    Brocks DR, Jamali F.
    Clin Pharmacokinet; 1994 Apr 17; 26(4):259-74. PubMed ID: 8013160
    [Abstract] [Full Text] [Related]

  • 28. Liquid chromatographic enantioseparation of (RS)-etodolac using (S)-levofloxacin and determination of absolute configuration of the diastereomeric derivatives.
    Singh M.
    Biomed Chromatogr; 2019 Mar 17; 33(3):e4415. PubMed ID: 30357876
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Dextran-etodolac conjugates: synthesis, in vitro and in vivo evaluation.
    Vyas S, Trivedi P, Chaturvedi SC.
    Acta Pol Pharm; 2009 Mar 17; 66(2):201-6. PubMed ID: 19719056
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Resolution of (+/-)-2-tetradecyloxiranecarboxylic acid. Absolute configuration and chiral synthesis of the hypoglycemic R enantiomer and biological activity of enantiomers.
    Ho W, Tarhan O, Kiorpes TC, Tutwiler GF, Mohrbacher RJ.
    J Med Chem; 1987 Jun 17; 30(6):1094-7. PubMed ID: 3585906
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of etodolac enantiomers in the rat after administration of phenobarbital or cimetidine.
    Brocks DR, Jamali F.
    Eur J Drug Metab Pharmacokinet; 1992 Jun 17; 17(4):293-9. PubMed ID: 1301359
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.